Latest News
5 July 2024
Lixa teams up with UQ on new ARC training centre to tackle antimicrobial resistance in agribusiness and environment
A new training Centre led by The University of Queensland is partnering with industry to tackle the global crisis of antimicrobial-resistant infections, which affect humans, animals and the environment.
27 June 2024
Lixa receives ethics approval for Phase I trial of NeoX-101
Lixa is delighted to announce that we have received Human Research Ethics Committee (HREC) approval to commence our first human trial - a Phase I clinical trial assessing the safety and tolerability of NeoX™ in an inhaled formulation.
14 Aug 2023
Lixa: Revolutionizing Anti-Infection Treatments and Raising Awareness on Antimicrobial Resistance
Lixa, an emerging biotech startup based in Western Australia, is on a mission to resolve recurring microbial infections and contaminations by developing a novel approach that makes resistant bacteria vulnerable to antibiotics and the immune system again.
5 July 2023
Mila and Lixa Partner to Tackle Antimicrobial Resistance
Mila – Quebec AI Institute, the world’s largest academic deep learning (DL) research center has today announced a new partnership with biotechnology company, Lixa. The collaboration brings together Lixa’s antibiofilm knowledge and capabilities and Mila’s expertise in artificial intelligence (AI), igniting a beacon of hope in the battle against one of the greatest threats to global health.
20 Oct 2022
Blog: The role of water in antimicrobial resistance
One Health is a concept that recognises that the health of humans, animals and the environment are interconnected. In particular, this concept applies extremely well to the problem of antimicrobial resistance (AMR). Inspired by this week being National Water Week and the World Health Organisation’s One Health approach, we examine the connection between water and the rise of AMR.